These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 1585286
1. Examinations of the relative fluidity in cerebrovascular disease patients. Szobor A, Klein M. Ther Hung; 1992; 40(1):8-11. PubMed ID: 1585286 [Abstract] [Full Text] [Related]
3. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease]. Szapáry L, Horváth B, Alexy T, Márton Z, Késmárky G, Szóts M, Nagy F, Czopf J, Tóth K. Orv Hetil; 2003 May 18; 144(20):973-8. PubMed ID: 12830727 [Abstract] [Full Text] [Related]
4. Effect of vinpocetine on red blood cell deformability in stroke patients. Hayakawa M. Arzneimittelforschung; 1992 Apr 18; 42(4):425-7. PubMed ID: 1642666 [Abstract] [Full Text] [Related]
5. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Osawa M, Maruyama S. Ther Hung; 1985 Apr 18; 33(1):7-12. PubMed ID: 3842000 [No Abstract] [Full Text] [Related]
6. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders. Tamaki N, Kusunoki T, Matsumoto S. Ther Hung; 1985 Apr 18; 33(1):13-21. PubMed ID: 3841996 [No Abstract] [Full Text] [Related]
7. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion. Bacher A, Eggensperger E, Koppensteiner R, Mayer N, Klimscha W. Acta Anaesthesiol Scand; 2005 Jan 18; 49(1):41-6. PubMed ID: 15675980 [Abstract] [Full Text] [Related]
8. Open-labeled phase III clinical trials with vinpocetine in Japan. Ebi O. Ther Hung; 1985 Jan 18; 33(1):41-9. PubMed ID: 3915913 [No Abstract] [Full Text] [Related]
9. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine]. Tamaki N, Matsumoto S. Nihon Rinsho; 1985 Feb 18; 43(2):376-8. PubMed ID: 2987571 [No Abstract] [Full Text] [Related]
10. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies]. Burtsev EM, Shprakh VV, Savkov VS. Ross Med Zh; 1992 Feb 18; (2):41-3. PubMed ID: 1643337 [No Abstract] [Full Text] [Related]
11. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline. Ott E, Lechner H. Ric Clin Lab; 1981 Feb 18; 11 Suppl 1():253-6. PubMed ID: 7188113 [Abstract] [Full Text] [Related]
12. In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model. Horvath B, Vekasi J, Kesmarky G, Toth K. Clin Hemorheol Microcirc; 2008 Feb 18; 40(2):165-6. PubMed ID: 19029641 [No Abstract] [Full Text] [Related]
14. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients]. Sapary L, Horvath B, Alexy T, Marton Z, Kesmarky G, Zsots M, Nagy F, Czopf I, Toth K. Zh Nevrol Psikhiatr Im S S Korsakova; 2006 Feb 18; 106(6):47-51. PubMed ID: 16841484 [No Abstract] [Full Text] [Related]
15. Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study. Alkuraishy HM, Al-Gareeb AI, Albuhadilly AK. Biomed Res Int; 2014 Feb 18; 2014():324307. PubMed ID: 25548768 [Abstract] [Full Text] [Related]
17. The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases. Miyazaki M. Angiology; 1995 Jan 18; 46(1):53-8. PubMed ID: 7818157 [Abstract] [Full Text] [Related]
20. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency]. Ishchenko MM, Shkrobot SI. Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Jan 18; 85(9):1338-42. PubMed ID: 4072532 [Abstract] [Full Text] [Related] Page: [Next] [New Search]